EPharmacy Workshop 17 March 2008-Minutes: Difference between revisions

From IHE Wiki
Jump to navigation Jump to search
Simon.letellier (talk | contribs)
No edit summary
 
(24 intermediate revisions by 3 users not shown)
Line 1: Line 1:
=='''Under Construction'''==
==Venue==
==Venue==
*Brussels, 17 March 2008 from 10-17hr
*Brussels, 17 March 2008 from 10-17hr
Line 5: Line 4:
==Participants==
==Participants==
*Belgium : P. Houben (APB)
*Belgium : P. Houben (APB)
*France : J. Surugue (EAHP), F. Gener (Phast), T. Mitouarzo (Mc.Kesson), N. Canu (Phast), S. Letellier (EAHP/Phast), J. Nies (Medasys), E. Serrot (Vidal), A. Estelrich(DMP)
*France : J. Surugue (EAHP), F. Gener (Phast), T. Mitouard (Mc.Kesson), N. Canu (Phast), S. Letellier (EAHP/Phast), J. Nies (Medasys), E. Serrot (Vidal), A. Estelrich (DMP)
*Greece : L. Tzimis (EAHP)
*Greece : L. Tzimis (EAHP)
*Netherlands : A. Blom (KNMP), M. Sprenger(NICTIZ), R. Moss (EAHP)
*Netherlands : A. Blom (KNMP), M. Sprenger(NICTIZ), R. Moss (EAHP)
Line 14: Line 13:
==All Documents==
==All Documents==
*Ftp site : [ftp://ftp.ihe.net/International/Europe/Development/Pharmacy/Meetings/Meeting17March2008/ ftp://ftp.ihe.net/International/Europe/Development/Pharmacy/Meetings/Meeting17March2008/]
*Ftp site : [ftp://ftp.ihe.net/International/Europe/Development/Pharmacy/Meetings/Meeting17March2008/ ftp://ftp.ihe.net/International/Europe/Development/Pharmacy/Meetings/Meeting17March2008/]
*Zip archive: [ftp://ftp.ihe.net/International/Europe/Development/Pharmacy/Meetings/Meeting17March2008/_ePharmacy%20workshop%2017032008%20Archive.zip here]


==Update on e-pharmacy activities==  
==Update on e-pharmacy activities==  
* ASHP (American Society of Pharmacist)  
* ASHP ([http://www.ashp.org American Society of Health-System Pharmacists])  
** Debrief meeting at HIMSS : [ftp://ftp.ihe.net/International/Europe/Development/Pharmacy/Meetings/Meeting17March2008/ASHP.ppt summary]
** Debriefing of HIMSS meeting : [ftp://ftp.ihe.net/International/Europe/Development/Pharmacy/Meetings/Meeting17March2008/ASHP.ppt summary]
** ASHP is open to co-operate; initially to review the proposed use cases; in a later phase as member/sponsor of the global IHE Pharmacy domain. Primary focus is hospital pharmacy
** ASHP is open to co-operate; initially to review the proposed use cases; in a later phase as member/sponsor of the global IHE Pharmacy domain. Primary focus is hospital pharmacy
* HITSP [ftp://ftp.ihe.net/International/Europe/Development/Pharmacy/Meetings/Meeting17March2008/USA-HITSP%20Technical%20Committee%20Orientation%20Session%203%2013%2008.pdf overview] :
* HITSP [ftp://ftp.ihe.net/International/Europe/Development/Pharmacy/Meetings/Meeting17March2008/USA-HITSP%20Technical%20Committee%20Orientation%20Session%203%2013%2008.pdf overview] :
Line 28: Line 28:
*Scope : the initial Use Cases will be developed for drug related workflow. In a later phase, additional Use Cases will be developped for handling sterialized medical supplies (e.g. catheders) and  chemicals/regents (e.g. acetone)   
*Scope : the initial Use Cases will be developed for drug related workflow. In a later phase, additional Use Cases will be developped for handling sterialized medical supplies (e.g. catheders) and  chemicals/regents (e.g. acetone)   
*Use Case priorities are re-confirmed :
*Use Case priorities are re-confirmed :
**Prio 1: Electronic transfer of prescriptions (community & hospital pharmacy), medication management (community pharmacy)
*Hospital Pharmacy use cases :
**Prio 2: Medication management for hospital pharmacy (intake&discharge medication)
**Use Case Team : F. Gener/N. Canu (principal editors), T. Mitouarzo, S. Letellier , R. Moss , L. Tzimis  S. Cozzolino  , J. Surugue
*Hospital Pharmacy Use Cases :
**High level proposal : here .  
**Use Case Team : F. Gener/N. Canu (principal editors), T. Mitouard, S. Letellier , R. Moss , L. Tzimis, S. Cozzolino  , J. Surugue, I. Gibaud, V. Mary
**Proposal defines 4 main use cases and are a generalization/simplification of hospital pharmacy use cases for France
**High level proposal : [ftp://ftp.ihe.net/International/Europe/Development/Pharmacy/Meetings/Meeting17March2008/20080316_IHE_Pharmacy_hospital_use_cases.04.doc here] .  
**Feedback
**Proposal is a generalization/simplification of hospital pharmacy use cases for France and defines 4 main use cases 
**Feedback :
***Add actor “Prescription validator” who analysis and validates the prescription
***Add actor “Prescription validator” who analysis and validates the prescription
***Add new transaction between “Prescriber and Prescription validator” to propose alternative prescription is the initial prescription is rejected
***Add new transaction between “Prescriber and Prescription validator” to propose alternative prescription when the initial prescription is rejected
***Add actor (“Medication Publisher/Subscribers”) and transactions to publish medication information to multiple Medication Subscribers (e.g. to include mediation history in the patient’s EHR)
***Add actor (“Medication Publisher/Subscribers”) and transactions to publish medication information to multiple Medication Subscribers (e.g. to include mediation history in the patient’s EHR)
**Updated document will be presented at the next ftf meeting
**Updated document will be presented at the next ftf meeting
*Community Pharmacy use cases :
*Community Pharmacy use cases :
**Use Case Team :  Juan Suarez (principal editor), P. Houben, E. Serrot, A. Estelrich, A. Blom, M. Sprenger,  
**Use Case Team :  Juan Suarez (principal editor), P. Houben, E. Serrot, A. Estelrich, A. Blom, M. Sprenger,  
**High level proposal : here (Spain) and here (France, briefly discussed since author was not present).
**High level proposal : [ftp://ftp.ihe.net/International/Europe/Development/Pharmacy/Meetings/Meeting17March2008/ePharmacy%20ePrescription%20use%20cases%20Spain.doc Use Cases Spain] and [ftp://ftp.ihe.net/International/Europe/Development/Pharmacy/Meetings/Meeting17March2008/20080308_IHE_Bruxelles_medication_sharing.doc Use Cases France] (briefly discussed by absense of the author)
**Focus on medication managment and prescription managment
**Focus on medication management and prescription management
**Feedback
**Feedback
***Use cases must support a document centric architecture (e-prescriptions are handled as persistent documents) which is complementary to message centric architecture of hospital pharmacy. However a similar approach exists in other IHE domains where extra-hospital workflow is document centric (e.g. XDS) and intra-hospital workflow is message centric (e.g. IHE scheduled workflow)
***Use cases must support a document centric architecture (e-prescriptions are handled as persistent documents) which is complementary to message centric architecture of hospital pharmacy. This is in line with the other IHE domains where extra-hospital workflow is document centric (e.g. XDS) and intra-hospital workflow is message centric (e.g. IHE scheduled workflow)
***Use Cases support a push model (direct transmission of e-prescription between GP and Pharmacist) and a push-pull model (e-prescription is stored in an intermediate repository).   
***Use Cases should support a push model (direct transmission of e-prescription between GP and Pharmacist) and a push-pull model (e-prescription is stored in an intermediate repository).   
*** Add XDS actors (document repository/registry)  
*** Add XDS actors (document repository/registry)  
*** Add actor (“Medication Publisher/Subscribers”) and transactions to publish dispensed medication information to multiple Medication Subscribers (e.g. to include dispensed mediation in the patient’s EHR)
*** Add actor (“Medication Publisher/Subscribers”) and transactions to publish dispensed medication information to multiple Medication Subscribers (e.g. to include dispensed mediation in the patient’s EHR)
*** Medication history only contains dispensed medication, not information about contra-conditions, allergies
*** Medication history should only contain dispensed medication, not information about contra-conditions, alergies
*** Align the actor definition with hospital pharmacy actors
*** Align the actor definition with hospital pharmacy actors
***Add actor “Prescription validator” who analysis and validates the prescription
***Add actor “Prescription validator” who analysis and validates the prescription
***Add new transaction between “Prescriber and Prescription validator” to propose alternative prescription is the initial prescription is rejected
***Add new transaction between “Prescriber and Prescription validator” to propose alternative prescription when the initial prescription is rejected
*** Add actor (“Medication Publisher/Subscribers”) and transactions to publish medication information to multiple Medication Medication Subscribers (e.g. an EHR document producer)
*** Add actor (“Medication Publisher/Subscribers”) and transactions to publish medication information to multiple Medication Medication Subscribers (e.g. an EHR document producer)
**Updated document will be presented at the next ftf meeting
**Updated document will be presented at the next ftf meeting


==Next steps ==
==Next steps ==
*Involve other countries : Germany and UK (Jacqueline)
*Involve other countries : Germany and UK (J. Surugue)
*Future : drug agencies (e.g. MIA)
*And in the future, the drug agencies (e.g. EMEA)


==Timing==
==Timing==
*June 2008 : Finalise main Use Case; submit to IHE Development committee
 
*Mid 2008 – Mid 2009 : profile development (as IHE Development committee)
Comment: Should submit application to form IHE Pharmacy Domain to the IHE Board in Mid-2008
*2010 : Test implementations at connectathons
 
*June 2008 : Finalise main Use Case; submit to global IHE Development committee
*Mid 2008 – Mid 2009 : profile development (as global IHE Pharmacy committee)
*2010 : Test IHE Pharmacy implementations at connectathons

Latest revision as of 08:54, 22 April 2008

Venue

  • Brussels, 17 March 2008 from 10-17hr

Participants

  • Belgium : P. Houben (APB)
  • France : J. Surugue (EAHP), F. Gener (Phast), T. Mitouard (Mc.Kesson), N. Canu (Phast), S. Letellier (EAHP/Phast), J. Nies (Medasys), E. Serrot (Vidal), A. Estelrich (DMP)
  • Greece : L. Tzimis (EAHP)
  • Netherlands : A. Blom (KNMP), M. Sprenger(NICTIZ), R. Moss (EAHP)
  • Italy : S. Cozzolino (EAHP)
  • Spain : Juan Suarez (Indra)
  • IHE Eur : G. Claeys (Agfa Healthcare), C. Parisot (GE Healthcare)

All Documents

Update on e-pharmacy activities

  • ASHP (American Society of Health-System Pharmacists)
    • Debriefing of HIMSS meeting : summary
    • ASHP is open to co-operate; initially to review the proposed use cases; in a later phase as member/sponsor of the global IHE Pharmacy domain. Primary focus is hospital pharmacy
  • HITSP overview :
    • HITSP is an initiative of the USA government to develop healthcare IT standards for different clinical domain, incuding e-pharmacy. A draft specification for medication management is available here which focuses on workflow among hospital/consumers/pharmacists and health insurances.
    • Action : Identify the sections in the proposal that can be re-used for our community pharmacy Use Cases.

Use Cases :

ePharmacy Use Cases

  • Overview : mindmap
  • Scope : the initial Use Cases will be developed for drug related workflow. In a later phase, additional Use Cases will be developped for handling sterialized medical supplies (e.g. catheders) and chemicals/regents (e.g. acetone)
  • Use Case priorities are re-confirmed :
    • Prio 1: Electronic transfer of prescriptions (community & hospital pharmacy), medication management (community pharmacy)
    • Prio 2: Medication management for hospital pharmacy (intake&discharge medication)
  • Hospital Pharmacy Use Cases :
    • Use Case Team : F. Gener/N. Canu (principal editors), T. Mitouard, S. Letellier , R. Moss , L. Tzimis, S. Cozzolino , J. Surugue, I. Gibaud, V. Mary
    • High level proposal : here .
    • Proposal is a generalization/simplification of hospital pharmacy use cases for France and defines 4 main use cases
    • Feedback :
      • Add actor “Prescription validator” who analysis and validates the prescription
      • Add new transaction between “Prescriber and Prescription validator” to propose alternative prescription when the initial prescription is rejected
      • Add actor (“Medication Publisher/Subscribers”) and transactions to publish medication information to multiple Medication Subscribers (e.g. to include mediation history in the patient’s EHR)
    • Updated document will be presented at the next ftf meeting
  • Community Pharmacy use cases :
    • Use Case Team : Juan Suarez (principal editor), P. Houben, E. Serrot, A. Estelrich, A. Blom, M. Sprenger,
    • High level proposal : Use Cases Spain and Use Cases France (briefly discussed by absense of the author)
    • Focus on medication management and prescription management
    • Feedback
      • Use cases must support a document centric architecture (e-prescriptions are handled as persistent documents) which is complementary to message centric architecture of hospital pharmacy. This is in line with the other IHE domains where extra-hospital workflow is document centric (e.g. XDS) and intra-hospital workflow is message centric (e.g. IHE scheduled workflow)
      • Use Cases should support a push model (direct transmission of e-prescription between GP and Pharmacist) and a push-pull model (e-prescription is stored in an intermediate repository).
      • Add XDS actors (document repository/registry)
      • Add actor (“Medication Publisher/Subscribers”) and transactions to publish dispensed medication information to multiple Medication Subscribers (e.g. to include dispensed mediation in the patient’s EHR)
      • Medication history should only contain dispensed medication, not information about contra-conditions, alergies
      • Align the actor definition with hospital pharmacy actors
      • Add actor “Prescription validator” who analysis and validates the prescription
      • Add new transaction between “Prescriber and Prescription validator” to propose alternative prescription when the initial prescription is rejected
      • Add actor (“Medication Publisher/Subscribers”) and transactions to publish medication information to multiple Medication Medication Subscribers (e.g. an EHR document producer)
    • Updated document will be presented at the next ftf meeting

Next steps

  • Involve other countries : Germany and UK (J. Surugue)
  • And in the future, the drug agencies (e.g. EMEA)

Timing

Comment: Should submit application to form IHE Pharmacy Domain to the IHE Board in Mid-2008

  • June 2008 : Finalise main Use Case; submit to global IHE Development committee
  • Mid 2008 – Mid 2009 : profile development (as global IHE Pharmacy committee)
  • 2010 : Test IHE Pharmacy implementations at connectathons